Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenoconversion Risk in CYP2D6 Extensive Metabolizers
NCT03054220Completed
- Start
- Jul 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Open-label trial of duloxetine and paroxetine. Started Jul 2016; status: completed.
02
Drugs
duloxetineparoxetine
Beyond the preview
Go deeper on NCT03054220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03054220.